DJIA 17,757.91 138.40 0.79%
NASDAQ 5,013.12 26.26 0.53%
S&P 500 2,077.42 14.31 0.69%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

126.19 2.71 (2.19%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $126.19 2.19%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $124.11
Previous Close $123.48
Daily Range $124.10 - $126.65
52-Week Range $84.41 - $137.50
Market Cap $30.8B
P/E Ratio -41.58
Dividend (Yield) $0.00 (0.0%)
Volume 1,451,130
Average Daily Volume 1,258,727
Current FY EPS -$2.12

Sector

Healthcare

Industry

Drug Makers

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary

The Highest Paid CEOs in Biotech

These highest paid CEOs in biotech brought in a minimum of $24 million in compensation in 2014. Find out what makes these leaders so special, and whether or not their exorbitant pay packages are sustainable.

Andreas Halvorsen Increases Stake in Esperion Therapeutics

Vertex Profits Hinge on FDA Approving New Cystic Fibrosis Drug This Week

Vertex Pharma: Well Positioned To Set New Highs

Benzinga's Top #PreMarket Gainers

Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Leader Stock

Biotech Stock Roundup: BioMarin Jumps on Dwarfism Data, Vical Plunges on Vaccine Data - Analyst Blog

3 Stocks Raising The Health Care Sector Higher

Pre-Clinical Data Shows Huge Potential For Resunab In Treating CF

The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutic

The Zacks Analyst Blog Highlights: Regeneron, Vertex, Celgene, Seattle Genetics and SAGE Therapeutics - Press Releases

Vertex Pharma Offers Data Presentations at ECFS Conference: TRAFFIC, TRANSPORT Extension Study of Lu

Vertex Pharma Offers Data Presentations at ECFS Conference: TRAFFIC, TRANSPORT Extension Study of Lumacaftor Im Combo with Ivacaftor Showed Improvements

See More VRTX News...

VRTX's Top Competitors

VRTX $126.19 (2.19%)
Current stock: VRTX
AMGN $154.99 (0.96%)
Current stock: AMGN
GILD $116.01 (-0.91%)
Current stock: GILD
BIIB $405.41 (0.36%)
Current stock: BIIB